Literature DB >> 20695853

Chronic telogen effluvium is due to a reduction in the variance of anagen duration.

Stephen Gilmore1, Rodney Sinclair.   

Abstract

BACKGROUND/
OBJECTIVES: Chronic telogen effluvium and diffuse cyclical hair loss in women are well-described clinical entities characterized by chronic and fluctuating increases in hair shedding without loss of hair volume. We sought to investigate the follicular dynamics of chronic telogen effluvium and diffuse cyclical hair loss using a previously validated computer simulation known as the follicular automaton.
METHODS: Using our model, we were able to simulate reductions in both the mean and variance of anagen duration and thus investigate their consequences with respect to both hair volume and hair shedding.
RESULTS: We showed that reducing the mean anagen duration results in a loss of hair volume without prominent fluctuations in hair fall: findings that reproduced the key features in androgenetic alopecia. In contrast, a reduction in the variance of anagen duration generated follicular dynamics that accurately reproduced the known key features of chronic telogen effluvium and diffuse cyclical hair loss: acute exacerbations, periodicity and only minimal reductions in long-term hair volume.
CONCLUSIONS: We provide evidence that suggests chronic telogen effluvium may be secondary to a reduction in the variance of anagen and suggest this pathological state represents a new functional type of recurrent hair shedding.

Entities:  

Mesh:

Year:  2010        PMID: 20695853     DOI: 10.1111/j.1440-0960.2010.00654.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  8 in total

1.  Possible Relationship between Chronic Telogen Effluvium and Changes in Lead, Cadmium, Zinc, and Iron Total Blood Levels in Females: A Case-Control Study.

Authors:  Abeer M Abdel Aziz; Sameera Sh Hamed; Mohammad A Gaballah
Journal:  Int J Trichology       Date:  2015 Jul-Sep

Review 2.  Female pattern hair loss.

Authors:  Ingrid Herskovitz; Antonella Tosti
Journal:  Int J Endocrinol Metab       Date:  2013-10-21

3.  Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study.

Authors:  Eshini Perera; Rodney Sinclair
Journal:  F1000Res       Date:  2017-09-06

Review 4.  Telogen Effluvium: A Review of the Literature.

Authors:  Fahham Asghar; Nazia Shamim; Umar Farooque; Haris Sheikh; Ramsha Aqeel
Journal:  Cureus       Date:  2020-05-27

5.  Comparative evaluation between two nutritional supplements in the improvement of telogen effluvium.

Authors:  Flávia Alvim Sant'Anna Addor; Ludmila Coelho Donato; Camila Sirieiro Abreu Melo
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-09-10

6.  Telogen effluvium x female pattern hair loss: is there correlation?

Authors:  Fabiane Mulinari Brenner; Carolina Oldoni
Journal:  An Bras Dermatol       Date:  2019-10-17       Impact factor: 1.896

7.  Clinical and histological challenge in the differential diagnosis of diffuse alopecia: female androgenetic alopecia, telogen effluvium and alopecia areata--part II.

Authors:  Betina Werner; Fabiane Mulinari-Brenner
Journal:  An Bras Dermatol       Date:  2012 Nov-Dec       Impact factor: 1.896

8.  Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management.

Authors:  Michela Starace; Matilde Iorizzo; Andrea Sechi; Aurora Maria Alessandrini; Miriam Carpanese; Francesca Bruni; Giulio Vara; Zoe Apalla; Daniel Asz-Sigall; Stefania Barruscotti; Francisco Camacho; Isabella Doche; Bruna Duque Estrada; Rachita Dhurat; Maria Fernanda Gavazzoni; Ramon Grimalt; Matthew Harries; Dimitrios Ioannidis; Amy McMichael; Daniel Fernandes Melo; Rui Oliveira; Yuliya Ovcharenko; Rodrigo Pirmez; Yuval Ramot; Lidia Rudnicka; Jerry Shapiro; Tatiana Silyuk; Rodney Sinclair; Antonella Tosti; Sergio Vano-Galvan; Bianca Maria Piraccini
Journal:  JAAD Int       Date:  2021-08-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.